Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Pharmacoeconomics and Health Outcomes' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Stakeholder Insight: Pricing and Reimbursement in Oncology Do payers believe oncology drugs offer good value? |
Dec 2006 | £7,210 | 100% |
| Pricing and Reimbursement in the US Innovation and robust pharmacoeconomic analysis are ke |
Jun 2006 | £4,110 | 99% |
| How Drugs Are Developed 3rd Edition |
Jan 2007 | £1,095 | 96% |
| Creating compelling market access stories | Aug 2011 | £355 | 85% |
| Health Technology Assessment (HTA) A European perspective |
Oct 2011 | £735 | 84% |
| Pricing and Reimbursement in Key Asia Pacific Markets | Jan 2009 | £2,405 | 82% |
| Stakeholder Insight: Alzheimer's Disease Prescribing trends indicate that neurologists are not adhering to guidelines |
Dec 2006 | £8,365 | 77% |
| Chemotherapy Market Insights, 2006-2016 A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities |
Apr 2006 | £1,900 | 75% |
| Cancer Biomarkers Enhancing diagnostic, therapeutic and developmental strategies |
May 2006 | £1,390 | 74% |
| Global Trends in Reimbursement of Medical Technology | Jan 2007 | £1,300 | 73% |
| Pricing & Reimbursement in Europe Can the drive for cost effectiveness overcome cost containment? |
Oct 2006 | £7,210 | 72% |
| Croatia Pharmaceuticals and Healthcare Report Q2 2011 |
Feb 2011 | £330 | 72% |
| Tomorrow's KOLs: the changing face of influence | Sep 2010 | £295 | 72% |
| Alzheimer's disease Technologies, Markets and Companies |
Jan 2012 | £2,265 | 67% |
| Companion Diagnostics in Personalized Medicine and Cancer Therapy | Jul 2011 | £2,150 | 59% |
- Results 1 - 15 of 15
-
-
- 1
-
-
